Retained Earnings (Accumulated Deficit) of INFINITY PHARMACEUTICALS, INC. from 31 Dec 2010 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- The cumulative amount of the reporting entity's undistributed earnings or deficit.
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2010 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Jun 2023 was $876,953,000, a 4.9% decline year-over-year.
- Source SEC data
- View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Retained Earnings (Accumulated Deficit) (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $876,953,000 | -$40,948,000 | -4.9% | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $866,997,000 | -$42,978,000 | -5.2% | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | $855,952,000 | -$44,369,000 | -5.5% | 31 Dec 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $846,722,000 | -$46,790,000 | -5.8% | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $836,005,000 | -$46,786,000 | -5.9% | 30 Jun 2022 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $824,019,000 | -$46,069,000 | -5.9% | 31 Mar 2022 | 10-Q | 03 May 2022 | 2022 | Q1 |
| Q4 2021 | $811,583,000 | -$45,262,000 | -5.9% | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2021 | $799,932,000 | -$44,210,000 | -5.8% | 30 Sep 2021 | 10-Q | 02 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $789,219,000 | -$43,031,000 | -5.8% | 30 Jun 2021 | 10-Q | 27 Jul 2021 | 2021 | Q2 |
| Q1 2021 | $777,950,000 | -$41,235,000 | -5.6% | 31 Mar 2021 | 10-Q | 13 May 2021 | 2021 | Q1 |
| Q4 2020 | $766,321,000 | -$40,492,000 | -5.6% | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
| Q3 2020 | $755,722,000 | -$41,275,000 | -5.8% | 30 Sep 2020 | 10-Q | 09 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $746,188,000 | -$43,158,000 | -6.1% | 30 Jun 2020 | 10-Q | 30 Jul 2020 | 2020 | Q2 |
| Q1 2020 | $736,715,000 | -$44,199,000 | -6.4% | 31 Mar 2020 | 10-Q | 11 May 2020 | 2020 | Q1 |
| Q4 2019 | $725,829,000 | -$47,057,000 | -6.9% | 31 Dec 2019 | 10-K | 16 Mar 2021 | 2020 | FY |
| Q3 2019 | $714,447,000 | -$43,895,000 | -6.5% | 30 Sep 2019 | 10-Q | 30 Oct 2019 | 2019 | Q3 |
| Q2 2019 | $703,030,000 | -$19,097,000 | -2.8% | 30 Jun 2019 | 10-Q | 30 Jul 2019 | 2019 | Q2 |
| Q1 2019 | $692,516,000 | -$15,546,000 | -2.3% | 31 Mar 2019 | 10-Q | 07 May 2019 | 2019 | Q1 |
| Q4 2018 | $678,772,000 | -$11,253,000 | -1.7% | 31 Dec 2018 | 10-K | 03 Mar 2020 | 2019 | FY |
| Q3 2018 | $670,552,000 | -$10,329,000 | -1.6% | 30 Sep 2018 | 10-Q | 05 Nov 2018 | 2018 | Q3 |
| Q2 2018 | $683,933,000 | -$30,815,000 | -4.7% | 30 Jun 2018 | 10-Q | 07 Aug 2018 | 2018 | Q2 |
| Q1 2018 | $676,970,000 | -$40,806,000 | -6.4% | 31 Mar 2018 | 10-Q | 08 May 2018 | 2018 | Q1 |
| Q4 2017 | $667,519,000 | -$41,830,000 | -6.7% | 31 Dec 2017 | 10-K | 14 Mar 2019 | 2018 | FY |
| Q3 2017 | $660,223,000 | -$57,464,000 | -9.5% | 30 Sep 2017 | 10-Q | 07 Nov 2017 | 2017 | Q3 |
| Q2 2017 | $653,118,000 | -$69,857,000 | -12% | 30 Jun 2017 | 10-Q | 03 Aug 2017 | 2017 | Q2 |
| Q1 2017 | $636,164,000 | +$88,000 | +0.01% | 31 Mar 2017 | 10-Q | 09 May 2017 | 2017 | Q1 |
| Q4 2016 | $625,689,000 | -$30,101,000 | -5.1% | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q3 2016 | $602,759,000 | -$46,361,000 | -8.3% | 30 Sep 2016 | 10-Q | 09 Nov 2016 | 2016 | Q3 |
| Q2 2016 | $583,261,000 | +$15,681,000 | +2.6% | 30 Jun 2016 | 10-Q | 09 Aug 2016 | 2016 | Q2 |
| Q1 2016 | $636,252,000 | -$75,738,000 | -14% | 31 Mar 2016 | 10-Q | 04 May 2016 | 2016 | Q1 |
| Q4 2015 | $595,588,000 | -$128,376,000 | -27% | 31 Dec 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q3 2015 | $556,398,000 | -$129,528,000 | -30% | 30 Sep 2015 | 10-Q | 05 Nov 2015 | 2015 | Q3 |
| Q2 2015 | $598,942,000 | -$68,856,000 | -13% | 30 Jun 2015 | 10-Q | 06 Aug 2015 | 2015 | Q2 |
| Q1 2015 | $560,514,000 | -$68,452,000 | -14% | 31 Mar 2015 | 10-Q | 06 May 2015 | 2015 | Q1 |
| Q4 2014 | $467,212,000 | -$17,416,000 | -3.9% | 31 Dec 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q3 2014 | $426,870,000 | -$9,999,000 | -2.4% | 30 Sep 2014 | 10-Q | 10 Nov 2014 | 2014 | Q3 |
| Q2 2014 | $530,086,000 | -$147,153,000 | -38% | 30 Jun 2014 | 10-Q | 11 Aug 2014 | 2014 | Q2 |
| Q1 2014 | $492,062,000 | -$141,720,000 | -40% | 31 Mar 2014 | 10-Q | 06 May 2014 | 2014 | Q1 |
| Q4 2013 | $449,796,000 | -$126,780,000 | -39% | 31 Dec 2013 | 10-K | 24 Feb 2015 | 2014 | FY |
| Q3 2013 | $416,871,000 | -$140,840,000 | -51% | 30 Sep 2013 | 10-Q | 07 Nov 2013 | 2013 | Q3 |
| Q2 2013 | $382,933,000 | -$88,499,000 | -30% | 30 Jun 2013 | 10-Q | 08 Aug 2013 | 2013 | Q2 |
| Q1 2013 | $350,342,000 | -$70,568,000 | -25% | 31 Mar 2013 | 10-Q | 07 May 2013 | 2013 | Q1 |
| Q4 2012 | $323,016,000 | -$53,964,000 | -20% | 31 Dec 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q3 2012 | $276,031,000 | -$21,040,182 | -8.3% | 30 Sep 2012 | 10-Q | 06 Nov 2012 | 2012 | Q3 |
| Q2 2012 | $294,434,000 | -$51,387,901 | -21% | 30 Jun 2012 | 10-Q | 07 Aug 2012 | 2012 | Q2 |
| Q1 2012 | $279,774,000 | 31 Mar 2012 | 10-Q | 08 May 2012 | 2012 | Q1 | ||
| Q4 2011 | $269,052,000 | -$40,042,437 | -17% | 31 Dec 2011 | 10-K | 05 Mar 2013 | 2012 | FY |
| Q3 2011 | $254,990,818 | 30 Sep 2011 | 10-Q | 08 Nov 2011 | 2011 | Q3 | ||
| Q2 2011 | $243,046,099 | 30 Jun 2011 | 10-Q | 09 Aug 2011 | 2011 | Q2 | ||
| Q4 2010 | $229,009,563 | 31 Dec 2010 | 10-K | 13 Mar 2012 | 2011 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.